OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 14
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 14
Showing 14 citing articles:
Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal
Giuseppe Lippi, Mario Plebani
European Journal of Internal Medicine (2022) Vol. 108, pp. 102-103
Open Access | Times Cited: 10
Giuseppe Lippi, Mario Plebani
European Journal of Internal Medicine (2022) Vol. 108, pp. 102-103
Open Access | Times Cited: 10
Machine-learning-aided multiplexed nanoplasmonic biosensor for COVID-19 population immunity profiling
Aidana Beisenova, Wihan Adi, S. Janna Bashar, et al.
Sensors & Diagnostics (2023) Vol. 2, Iss. 5, pp. 1186-1198
Open Access | Times Cited: 5
Aidana Beisenova, Wihan Adi, S. Janna Bashar, et al.
Sensors & Diagnostics (2023) Vol. 2, Iss. 5, pp. 1186-1198
Open Access | Times Cited: 5
Serological testing for SARS-CoV-2: Advancements and future challenges
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 108, pp. 104-105
Open Access | Times Cited: 7
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 108, pp. 104-105
Open Access | Times Cited: 7
COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production
Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, et al.
Research Square (Research Square) (2024)
Open Access
Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, et al.
Research Square (Research Square) (2024)
Open Access
COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production
Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants
Léa Dépéry, Isabelle Bally, Axelle Amen, et al.
Microbiology Spectrum (2024) Vol. 13, Iss. 1
Open Access
Léa Dépéry, Isabelle Bally, Axelle Amen, et al.
Microbiology Spectrum (2024) Vol. 13, Iss. 1
Open Access
Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC — April–October 2021
Anne Schuster, Erik Kopping, Jo-Anne Caton, et al.
Annals of Epidemiology (2024)
Open Access
Anne Schuster, Erik Kopping, Jo-Anne Caton, et al.
Annals of Epidemiology (2024)
Open Access
Clinical pearls and pitfalls of SARS-CoV-2 serology
Giuseppe Lippi, Brandon Michael Henry
European Journal of Internal Medicine (2023) Vol. 111, pp. 24-26
Open Access | Times Cited: 1
Giuseppe Lippi, Brandon Michael Henry
European Journal of Internal Medicine (2023) Vol. 111, pp. 24-26
Open Access | Times Cited: 1
Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand
Parichart Permpikul, Surat Tongyoo, Chutikarn Chaimayo, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285737-e0285737
Open Access | Times Cited: 1
Parichart Permpikul, Surat Tongyoo, Chutikarn Chaimayo, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285737-e0285737
Open Access | Times Cited: 1
Response Rate to the 3rd and 4th Doses of BNT162b2 Vaccine in Cancer Patients Administered with Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
Aidana Beisenova, Wihan Adi, S. Janna Bashar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Aidana Beisenova, Wihan Adi, S. Janna Bashar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination
Silvia Schest, Claus Langer, Yuriko Stiegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Silvia Schest, Claus Langer, Yuriko Stiegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance
Francisco Rubio Llorente, Elisa Pérez‐Ramírez, Mayte Pérez‐Olmeda, et al.
Pathogens (2023) Vol. 12, Iss. 11, pp. 1360-1360
Open Access
Francisco Rubio Llorente, Elisa Pérez‐Ramírez, Mayte Pérez‐Olmeda, et al.
Pathogens (2023) Vol. 12, Iss. 11, pp. 1360-1360
Open Access
